<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-2 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-2</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-2</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of the role of older age groups (\u22655 years, adolescents, and adults) in poliovirus transmission in Pakistan, including age-specific susceptibility/immunity, shedding and mucosal immunity, incidence and case age distribution, contact/mobility patterns, vaccination history and campaign targets/coverage, environmental surveillance findings, and modeling estimates of contribution to transmission. Capture quantitative results (percentages, rates, odds ratios, R/FOI, coverage) with units and age bands where available, plus any counterevidence or limitations.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>paper_title</strong></td>
                        <td>str</td>
                        <td>Full title of the paper.</td>
                    </tr>
                    <tr>
                        <td><strong>year</strong></td>
                        <td>int</td>
                        <td>Publication year.</td>
                    </tr>
                    <tr>
                        <td><strong>study_period</strong></td>
                        <td>str</td>
                        <td>Timeframe of data collection or analysis (e.g., 2017-2019).</td>
                    </tr>
                    <tr>
                        <td><strong>setting_location</strong></td>
                        <td>str</td>
                        <td>Geographic setting within Pakistan (country/province/district; note cross-border Afghanistan if applicable).</td>
                    </tr>
                    <tr>
                        <td><strong>virus_type</strong></td>
                        <td>str</td>
                        <td>Type(s) of poliovirus studied: WPV1, cVDPV2, Sabin (OPV), mixed, or unspecified.</td>
                    </tr>
                    <tr>
                        <td><strong>study_design</strong></td>
                        <td>str</td>
                        <td>Study type (e.g., serosurvey, modeling, environmental surveillance, AFP surveillance analysis, outbreak investigation, household/secondary attack study, OPV challenge trial, phylogenetics).</td>
                    </tr>
                    <tr>
                        <td><strong>data_sources</strong></td>
                        <td>str</td>
                        <td>Primary data sources used (e.g., AFP case data, ES sample results, vaccination records, contact surveys, travel/mobility, genomic sequences).</td>
                    </tr>
                    <tr>
                        <td><strong>population_age_groups</strong></td>
                        <td>str</td>
                        <td>Age bands analyzed; specify bins (e.g., <5, 5–14, 15–24, 25+).</td>
                    </tr>
                    <tr>
                        <td><strong>includes_older_age_groups</strong></td>
                        <td>bool</td>
                        <td>Does the study include participants or analyses for older age groups (\u22655 years)?</td>
                    </tr>
                    <tr>
                        <td><strong>older_age_definition</strong></td>
                        <td>str</td>
                        <td>How the study defines 'older' (e.g., >5 years, \u226515 years, adults \u226518 years).</td>
                    </tr>
                    <tr>
                        <td><strong>sample_size_total</strong></td>
                        <td>int</td>
                        <td>Total sample size (if available).</td>
                    </tr>
                    <tr>
                        <td><strong>age_specific_incidence</strong></td>
                        <td>str</td>
                        <td>Age distribution of paralytic polio or infection (numerical where possible; e.g., proportion of cases in \u22655 years).</td>
                    </tr>
                    <tr>
                        <td><strong>adult_cases_reported</strong></td>
                        <td>bool</td>
                        <td>Were paralytic polio cases in adults/adolescents reported?</td>
                    </tr>
                    <tr>
                        <td><strong>adult_case_details</strong></td>
                        <td>str</td>
                        <td>Details on adolescent/adult cases (counts, ages, virus type, locations, dates).</td>
                    </tr>
                    <tr>
                        <td><strong>seroprevalence_by_age</strong></td>
                        <td>str</td>
                        <td>Neutralizing antibody seroprevalence by age band and antigen type (PV1/PV2/PV3), with percentages and confidence intervals if stated.</td>
                    </tr>
                    <tr>
                        <td><strong>mucosal_immunity_or_shedding_by_age</strong></td>
                        <td>str</td>
                        <td>OPV take, stool shedding rates/duration by age, or other mucosal immunity metrics (numerical if available).</td>
                    </tr>
                    <tr>
                        <td><strong>vaccination_history_by_age</strong></td>
                        <td>str</td>
                        <td>OPV/IPV dose history and time since last dose by age group; routine vs SIA; missed vaccination rates.</td>
                    </tr>
                    <tr>
                        <td><strong>waning_immunity_evidence</strong></td>
                        <td>str</td>
                        <td>Evidence for waning humoral/mucosal immunity with age or time since last OPV (statements and any quantitative measures).</td>
                    </tr>
                    <tr>
                        <td><strong>transmission_metrics_by_age</strong></td>
                        <td>str</td>
                        <td>Age-specific transmission metrics (e.g., force of infection, effective reproduction number, secondary attack rates) with values and units.</td>
                    </tr>
                    <tr>
                        <td><strong>contribution_of_older_to_transmission</strong></td>
                        <td>str</td>
                        <td>Estimates or qualitative statements of the fraction or role of \u22655 years in maintaining transmission (e.g., % of infections, reservoir role, model-inferred contribution).</td>
                    </tr>
                    <tr>
                        <td><strong>environmental_surveillance_findings</strong></td>
                        <td>str</td>
                        <td>ES detections linked to age-related immunity gaps, locations, genotypes, and temporal patterns.</td>
                    </tr>
                    <tr>
                        <td><strong>SIA_target_age_range</strong></td>
                        <td>str</td>
                        <td>Supplementary Immunization Activity (SIA) target ages (e.g., <5, <10, all ages) relevant to the study period.</td>
                    </tr>
                    <tr>
                        <td><strong>SIA_coverage_by_age</strong></td>
                        <td>str</td>
                        <td>SIA or routine coverage estimates by age group, including missed children in older age bands.</td>
                    </tr>
                    <tr>
                        <td><strong>effect_of_expanding_SIA_age_range</strong></td>
                        <td>str</td>
                        <td>Empirical or modeled impact of including older ages in SIAs on transmission/elimination (with quantitative results if provided).</td>
                    </tr>
                    <tr>
                        <td><strong>contact_patterns</strong></td>
                        <td>str</td>
                        <td>Age-specific contact patterns or mixing matrices used/observed; relevance to transmission by older ages.</td>
                    </tr>
                    <tr>
                        <td><strong>mobility_migration_findings</strong></td>
                        <td>str</td>
                        <td>Findings on population movement (e.g., cross-border travel, nomads, labor migration) involving older ages and implications for spread.</td>
                    </tr>
                    <tr>
                        <td><strong>phylogenetic_or_genomic_evidence</strong></td>
                        <td>str</td>
                        <td>Sequencing/phylogenetic evidence indicating transmission chains, silent circulation, or links implicating older age groups.</td>
                    </tr>
                    <tr>
                        <td><strong>surveillance_biases_or_limitations</strong></td>
                        <td>str</td>
                        <td>Biases/limitations affecting older ages (e.g., AFP sensitivity in adults, care-seeking, under-ascertainment).</td>
                    </tr>
                    <tr>
                        <td><strong>age_shift_over_time</strong></td>
                        <td>str</td>
                        <td>Evidence of changes in age distribution of infection/cases over time (e.g., increasing proportion in \u22655 years).</td>
                    </tr>
                    <tr>
                        <td><strong>key_results_summary</strong></td>
                        <td>str</td>
                        <td>2–3 sentence, information-dense summary of main findings about older age groups' role in transmission.</td>
                    </tr>
                    <tr>
                        <td><strong>key_numbers</strong></td>
                        <td>str</td>
                        <td>Concise list of the most important quantitative results (semicolon-separated; include units and age bands).</td>
                    </tr>
                    <tr>
                        <td><strong>strength_of_evidence</strong></td>
                        <td>str</td>
                        <td>Indicators of evidence strength (sample size, CIs, p-values, model validation, data completeness).</td>
                    </tr>
                    <tr>
                        <td><strong>counterevidence_or_null_findings</strong></td>
                        <td>str</td>
                        <td>Findings that argue against a major role of older ages (e.g., negligible adult susceptibility or transmission).</td>
                    </tr>
                    <tr>
                        <td><strong>notable_quotes</strong></td>
                        <td>str</td>
                        <td>Short, verbatim quotes (with context) that directly address older ages' role in transmission.</td>
                    </tr>
                </tbody>
            </table>
        </div>

    </div>
</body>
</html>